/

Other

/

Revance

Revance

Revance

Verified Nov 2026

Other

·

United States flag

Nashville, Tennessee

·

Since 2002

Revance is a biotechnology and aesthetics company headquartered in Nashville, Tennessee, founded in 2002. It is estimated to have 500 to 1,000 employees and annual revenue of roughly $250 to $500 million, and it is a subsidiary of Crown Laboratories. The company makes injectable neuromodulators, dermal fillers, and microneedling devices for aesthetic and therapeutic use, serving aesthetic clinics, healthcare providers, and distributors. In 2026 it reported distributing over one million SkinPen treatment kits to customers since January 2025.

Revance

Verified Nov 2026

AT A GLANCE

Founded

2002

Headquarters

United States flag

Nashville, Tennessee

Employees

500-1,000

Ownership

Revance at a glance

Revenue

$250-500M

Est. band

Employees

500-1,000

Founded

2002

Headquarters

Nashville, Tennessee

Certifications

ISO 13485

Import activity

35

Industries

Automotive

Electric Vehicles

Medical

Renewable Energy

Industrial Equipment

Consumer Goods

Sourcing and import activity

From US customs bill-of-lading records

US sea imports

35

Named foreign suppliers

27

Top origins

China

Chart of the supplier's US import shipment volume trend over time

Shared foreign counterparties do not establish that these companies buy from Revance.

What this tells a buyer

Revance reported distributing its one millionth DAXXIFY vial in the U.S. in September 2025 and over one million SkinPen treatment kits to customers since January 2025, according to company announcements.

Its products include DAXXIFY neuromodulator, the RHA dermal filler collection, and the SkinPen microneedling system, and it holds ISO 13485 certification.

The company operates as a subsidiary of Crown Laboratories and has a facility in San Diego, California, in addition to its Nashville headquarters.

Source: US customs bill-of-lading records and public filings · Last verified Nov 05, 2026

STABILITY SIGNALS

Established & active

24 years in operation (founded 2002).

Holds ISO 13485 certification(s) per public sources.

Overview

Revance is a biotechnology and aesthetics company headquartered in Nashville, Tennessee, founded in 2002. It is estimated to have 500 to 1,000 employees and annual revenue of roughly $250 to $500 million, and it is a subsidiary of Crown Laboratories. The company makes injectable neuromodulators, dermal fillers, and microneedling devices for aesthetic and therapeutic use, serving aesthetic clinics, healthcare providers, and distributors. In 2026 it reported distributing over one million SkinPen treatment kits to customers since January 2025.

At a glance

Attribute

Detail

Founded

2002

Headquarters

Nashville, Tennessee

Employees

500-1,000

Revenue

$250-500M (estimated)

Certifications

ISO 13485

What Revance makes

Its products include DAXXIFY neuromodulator, the RHA dermal filler collection, and the SkinPen microneedling system, and it holds ISO 13485 certification.

Certifications

Revance is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:

Trade and customs footprint

Revance reported distributing its one millionth DAXXIFY vial in the U.S. in September 2025 and over one million SkinPen treatment kits to customers since January 2025, according to company announcements. US customs bill-of-lading records list 35 inbound shipments across 27 foreign suppliers, with top origins including China.

Latest developments

Facilities

Revance is headquartered in Nashville, Tennessee. Public sources also reference these locations:

Company details

The company operates as a subsidiary of Crown Laboratories and has a facility in San Diego, California, in addition to its Nashville headquarters. Revance was founded in 2002, has an estimated 500-1,000 employees, and is headquartered in Nashville, Tennessee. On the LightSource stability read it is rated "Established & active": 24 years in operation (founded 2002). Holds ISO 13485 certification(s) per public sources.

Frequently asked questions

What does Revance do?

Revance is a biotechnology and aesthetics company headquartered in Nashville, Tennessee, founded in 2002. It is estimated to have 500 to 1,000 employees and annual revenue of roughly $250 to $500 million, and it is a subsidiary of Crown Laboratories. The company makes injectable neuromodulators, dermal fillers, and microneedling devices for aesthetic and therapeutic use, serving aesthetic clinics, healthcare providers, and distributors. In 2026 it reported distributing over one million SkinPen treatment kits to customers since January 2025.

Where is Revance headquartered?

Revance is headquartered in Nashville, Tennessee (1222 Demonbreun St, Nashville, Tennessee, 37203-3340).

When was Revance founded?

Revance was founded in 2002.

How big is Revance?

Revance has an estimated 500-1,000 employees, with revenue in the $250-500M range (estimated).

What certifications does Revance hold?

Revance lists ISO 13485 on its website. Confirm the certified scope for the specific plant producing your part.

Does Revance import from overseas suppliers?

US customs bill-of-lading records show 35 inbound shipments for Revance, with top origins including China.

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Nashville, Tennessee (HQ)Headquarters · United States
Nashville, Tennessee (HQ)1222 Demonbreun St, Nashville, Tennessee, 37203-3340, United StatesHeadquarters

Phone

+1 510-742-3400

Certification

ISO 13485

Evaluating suppliers like these?

This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.